HeartBeam Inc BEAT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
-
HeartBeam, Inc. Letter to Shareholders
-
HeartBeam Reports Second Quarter 2026 Results
-
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
-
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
Trading Information
- Previous Close Price
- $0.43
- Day Range
- $0.66–0.94
- 52-Week Range
- $0.36–3.98
- Bid/Ask
- $0.70 / $0.70
- Shares Outstanding
- 56.35M
- Market Cap
- $39.48M
- Volume/Avg
- 175M / 653,646
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 16
- Website
- https://www.heartbeam.com
Valuation
|
Metric
|
BEAT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.99 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BEAT
|
|---|---|
Quick Ratio | 3.55 |
Current Ratio | 3.66 |
Interest Coverage | — |
Quick Ratio
BEAT
Profitability
|
Metric
|
BEAT
|
|---|---|
Return on Assets (Normalized) | −248.02% |
Return on Equity (Normalized) | −453.57% |
Return on Invested Capital (Normalized) | −457.01% |
Return on Assets
BEAT
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|%!Xjnksh | LOCK|^H | $44B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|r@r | $14B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|dw?c | $12B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|Vnxw | $11B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|<f$% | $11B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|BF$N | $8B | |||
| HealthEquity Inc
HQY
| — | LOCK|R%yR | $7B | |||
| M3 Inc
MTHRF
| — | LOCK|#>k<? | $7B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|?v!$ | $7B | |||
| Doximity Inc Class A
DOCS
| — | LOCK|&SD | $5B |
United States